In a cohort study involving 597 patients treated with primary treatment for gastric cancer, the OS with positive expression of LOXL1, LOXL3, or LOXL4 was significantly shorter than with negative LOXL4 expression. The gene discussed is LOXL4; the disease is gastric cancer.